Innovative Molecules Expands Virology Pipeline with Novel EBV Antiviral Program

Contributed by: PR Newswire

Tags

IM-EBV-Antiviral-Prog

More Like This

PR Newswire associated0

Innovative Molecules Announces Completion of Phase 1 Program and Advancement to Phase 2 for Oral Adibelivir

PR Newswire associated0

Innovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250

PR Newswire associated0

Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis, an Ultra-Rare Disease

PR Newswire associated0

IRBM Reports Breakthrough in Zika Virus Drug Discovery

PR Newswire associated0

Biosyngen's first-in-class CAR-T asset targeting solid tumors has entered pivotal phase II trial, Phase I trial data debut at ESMO 2024 Annual Congress

Biotech company Eradivir is developing lead drug EV25 to treat influenza

PR Newswire associated0

RedHill Biopharma Advancing Opaganib Options For Ebola Virus Disease Outbreak

ACCESSWIRE logo

NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun